
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
This book reviews the potential of next-generation sequencing (NGS) in research on and management of colorectal cancer (CRC), a leading cause of death worldwide and one of the most biologically and clinically heterogeneous cancers. It critically discusses findings from recent large-scale studies, clinical trials and meta-analyses and offers an introduction to the management of CRC in the era of precision medicine. In CRC, dozens of driver and passenger mutations are associated with the malignant transformation of epithelial cells. Consequently, the book discusses recent advances in our understanding of the genetics of CRC as a biomarker, the advent of NGS technologies in modern genomics, and the impact of NGS technology on the management of CRC. Furthermore, it highlights the potential of NGS in the context of liquid biopsy and single-cell sequencing in CRC, as well as its role in shedding light on the link between gut microbiota, immune-checkpoint blockade and CRC. The book concludes with a chapter on the limitations and cost-effectiveness of NGS in CRC. Given its scope, the book will appeal to all those interested in learning about the potential of NGS in advancing CRC research and patient care.
This book investigates the transformative role of Next-Generation Sequencing (NGS) in understanding and treating colorectal cancer (CRC). It critically examines recent large-scale studies, clinical trials, and meta-analyses to provide an introduction to CRC management within the framework of precision medicine. The text delves into the genetic landscape of CRC, exploring driver and passenger mutations, and highlights how NGS technologies are advancing our comprehension of CRC genetics as biomarkers. It also addresses the impact of NGS on CRC management, including its application in liquid biopsy and single-cell sequencing, and its role in elucidating the connections between gut microbiota, immune-checkpoint blockade, and CRC. The book concludes by evaluating the limitations and cost-effectiveness of NGS in the context of CRC.
The book is positioned as a valuable resource for researchers and clinicians interested in the application of NGS to colorectal cancer. Its scope covers recent advancements, from genetic biomarkers to emerging techniques like liquid biopsy and single-cell sequencing. The discussion on precision medicine and the interplay with gut microbiota and immunotherapy suggests a focus on current and future treatment strategies. The inclusion of limitations and cost-effectiveness indicates a balanced perspective on the technology's practical implementation.
Page Count:
185
Publication Date:
2021-09-30
Publisher:
Springer International Publishing
ISBN-10:
3030538230
ISBN-13:
9783030538231
No comments yet. Be the first to share your thoughts!